| Targeting the cardiorenal syndrome: adenosine A1 antagonists | Webcasts available | Metra, Marco (Brescia, IT)
| Heart Failure (HF) | 993 |
| Non adherence to medication: scope of the problem and predictors | Webcasts available | Van der Wal, Martje (Groningen, NL)
| Heart Failure (HF) | 983 |
| Biomarkers | Webcast available | Mc Donagh TA (London, UK)
| | 9 |
| Response and adaptation to hypoxia | Webcasts available | Schumacker, Paul (Chicago, US)
| Basic Science | 702 |
| Devices in heart failure: How to optimize follow up | Webcasts available | Stellbrink C (Bielefeld, DE)
| | 699 |
| Unconventional end-points in heart failure trials. | Webcasts available | Cleland J G F (Kingston upon Hull, GB)
| | 689 |
| Inodilators and myosin activators. | Webcasts available | Nieminen, Markku S. (Helsinki, FI)
| | 651 |
| Assessment of symptoms in clinics and trials. | Webcasts available | Cleland J G F (Kingston upon Hull, GB)
| | 647 |
| Self-care behaviours: state of the art | Webcasts available | Jaarsma, Tiny (Groningen, NL)
| Heart Failure (HF) | 379 |
| What information does the clinician need from MRI? | Webcasts available | Bax JJ (Leiden, NL)
| | 365 |
| Assessing mitral insufficiency and its consequences in the individual patient | Webcasts available | THOMAS James D. (Cleveland, US)
| Valvular Heart Diseases | 361 |
| Unsolved issues | Webcasts available | Piepoli, Massimo F. (Piacenza, IT)
| | 320 |
| Heart failure with renal dysfunction: Are there new perspectives? | Webcasts available | Solomon S. (Boston, US)
| | 315 |
| Implications of the obesity and diabetes epidemic for heart failure : The European view | Webcast available | Voors, Adriaan A (Groningen, NL)
| Heart Failure (HF) | 310 |
| Use of CRT-P, CRT-D and ICD in Europe | Heart Failure Congress 2009 Presentation | Gasparini, Maurizio (Rozzano, IT)
| Heart Failure (HF) | 26 |
| Extending the indications for aldosterone antagonists | Webcasts available | Zannad, Faiez (Dommartin les Toul, FR)
| Heart Failure (HF) | 24 |
| Non cardiovascular mortality in heart failure trials. | Webcast Available | Solomon S. (Boston, US)
| | 20 |
| Treatment Strategies | Webcasts available | McKelvie, Robert (Hamilton, CA)
| Heart Failure (HF) | 1613 |
| Future directions | Webcasts available | Braunschweig, Frieder (Stockholm, SE)
| Heart Failure (HF) | 1605 |
| Mechanisms of diastolic dysfunction. How important are endothelial factors? | Webcasts available | Paulus, Walter (Amsterdam, NL)
| Heart Failure (HF) | 1351 |
| State of the art: prognostication | Webcasts available | Jourdain, Patrick (Pontoise, FR)
| Heart Failure (HF) | 1348 |
| Human embryonic stem cell-derived cardiomyocytes: Are they the real thing? | Webcasts available | Harding, Sian E. (London, GB)
| Basic Science | 1318 |
| Monitoring patient symptoms remotely: What skills are needed? | Webcasts available | Ekman, Inger (Goteborg, SE)
| Heart Failure (HF) | 1308 |
| Health economics for the clinician - what do we need to know? | Webcasts available | Cowie, Martin R. (London, GB)
| Heart Failure (HF) | 1036 |